| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $380,000 ) |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 000 | 5 | 11/30/2023 | NON-COMPETING CONTINUATION | $380,000 |
|
| Issue Date FY: 2023 ( Subtotal = $380,000 ) |
| 2023 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 001 | 4 | 1/27/2023 | NON-COMPETING CONTINUATION | $38,000 |
| 2023 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 000 | 4 | 11/11/2022 | NON-COMPETING CONTINUATION | $342,000 |
|
| Issue Date FY: 2022 ( Subtotal = $380,000 ) |
| 2022 | 2022 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 001 | 3 | 6/8/2022 | NON-COMPETING CONTINUATION | $38,000 |
| 2022 | 2022 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 000 | 3 | 11/5/2021 | NON-COMPETING CONTINUATION | $342,000 |
|
| Issue Date FY: 2021 ( Subtotal = $380,000 ) |
| 2021 | 2021 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 000 | 2 | 11/20/2020 | NON-COMPETING CONTINUATION | $342,000 |
| 2021 | 2021 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 001 | 2 | 5/24/2021 | NON-COMPETING CONTINUATION | $38,000 |
|
| Issue Date FY: 2020 ( Subtotal = $380,000 ) |
| 2020 | 2020 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 000 | 1 | 11/29/2019 | NEW | $380,000 |
| 2020 | 2020 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP STREET STE 103 | MEMPHIS | TN | 38103 | SHELBY | USA | Cardiovascular Diseases Research | 001 | 1 | 2/3/2020 | NEW | $0 |
|
|